Warning to patients and the public about the risks of synthetic cannabinoids

The Czech Republic is currently experiencing rapid changes in the availability of various molecules belonging to the cannabinoid group and the associated risks to human health. It is essential that the public understands the very different health risks of each group of cannabinoids and is able to navigate the fundamental differences in the effects and severity of health risks between natural and artificial (synthetic) cannabinoids.